Journal of Clinical Virology
Volume 47, Issue 1 , Pages 43-48, January 2010

Prevalence of human papillomavirus genotypes, and mucosal IgA anti-viral responses in women with cervical ectopy

  • Olga L. Monroy

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
  • ,
  • Cecilia Aguilar

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
  • ,
  • Marcela Lizano

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
  • ,
  • Fernando Cruz-Talonia

      Affiliations

    • Fundacion Cruz Talonia, Colegio Mexicano de Colposcopistas, Mexico D.F., Mexico
  • ,
  • Rosa M. Cruz

      Affiliations

    • Fundacion Cruz Talonia, Colegio Mexicano de Colposcopistas, Mexico D.F., Mexico
  • ,
  • Leticia Rocha-Zavaleta

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
    • Corresponding Author InformationCorresponding author. Tel.: +52 55 56229217; fax: +52 55 56229212.

Received 6 January 2009; received in revised form 29 September 2009; accepted 7 October 2009. published online 11 November 2009.

Abstract 

Background

Data on the prevalence of different human papillomavirus (HPV) genotypes and the associated mucosal immune response in women with cervical ectopy are scarce.

Objective

To assess the prevalence of different HPV genotypes and the mucosal anti-viral immune response in cervical ectopy.

Study design

Detection and typing of HPV DNA was determined in 141 women with cervical ectopy, 272 cytologically normal controls and 98 low-grade squamous intraepithelial lesions (LSIL) by PCR and direct sequencing. Mucosal IgA antibodies to HPV16 and HPV18 were evaluated in cervical mucus by ELISA.

Results

The prevalence of HPV in cervical ectopy was higher (73.7%) than that observed in control samples (30.5% in endocervix, and 1.8% in exocervix), but similar to the prevalence in LSIL (62.2%). Typing showed that the overall distribution frequency concerned 14 different genotypes, with HPV18 being the most prevalent in cervical ectopy (53.9%), whereas HPV16 predominated in LSIL (38.7%). High-risk HPV genotypes were 2.2 times more frequent in cervical ectopy than in the normal endocervix (p<0.0001). HPV infection in cervical ectopy patients was accompanied by a mucosal IgA-antibody response. Antibody reactivity to HPV18 was significantly higher than the response to HPV16.

Conclusion

Cervical ectopy is a risk factor for infection with high-risk HPV genotypes, in particular HPV18. Our results emphasize the need of further studies to clarify the oncogenic potential of this virus in cervical ectopy.

Abbreviations: HPV, human papillomavirus, LSIL, low-grade squamous intraepithelial lesion, PCR, polymerase chain reaction, HIV, human immunodeficiency virus, IgA, immunoglobulin A, IgG, immunoglobulin G, VLP, virus-like particle, ELISA, enzyme-linked immunosorbent assay, PRR, prevalence rate ratio, CI, confidence interval

Keywords: Human papillomavirus infection, Cervical ectopy, Human papillomavirus prevalence, Endocervical cells

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1386-6532(09)00498-3

doi:10.1016/j.jcv.2009.10.008

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 43-48, January 2010